Global Stelara Market Growth 2023-2029

Global Stelara Market Growth 2023-2029

The global Stelara market size is projected to grow from US$ 6251 million in 2022 to US$ 4953.9 million in 2029; it is expected to grow at a CAGR of -3.3% from 2023 to 2029.

United States market for Stelara is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Stelara is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Stelara is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Stelara players cover J & J, Celltrion and Pfizer, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

Stelara is the brand name for ustekinumab, which is a medication used to treat certain immune-mediated inflammatory conditions. It is primarily used for the treatment of psoriasis and psoriatic arthritis, but it may also be prescribed for other conditions such as Crohn's disease.

LPI (LP Information)' newest research report, the “Stelara Industry Forecast” looks at past sales and reviews total world Stelara sales in 2022, providing a comprehensive analysis by region and market sector of projected Stelara sales for 2023 through 2029. With Stelara sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Stelara industry.

This Insight Report provides a comprehensive analysis of the global Stelara landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Stelara portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Stelara market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Stelara and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Stelara.

This report presents a comprehensive overview, market shares, and growth opportunities of Stelara market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type
Brands
Biosimilar

Segmentation by application
Crohn's Disease
Ulcerative Colitis
Other

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
J & J
Celltrion
Pfizer

Key Questions Addressed in this Report

What is the 10-year outlook for the global Stelara market?

What factors are driving Stelara market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Stelara market opportunities vary by end market size?

How does Stelara break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Please note: The report will take approximately 2 business days to prepare and deliver.